UTAH MEDICAL PRODUCTS, INC. Operating Lease Liability
UTAH MEDICAL PRODUCTS, INC. (UTMD) had Operating Lease Liability of $286.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-27
- 2025-12-31: Operating Lease, Liability $286.00K.
- 2025-06-30: Operating Lease, Liability $256.00K.
- 2024-12-31: Operating Lease, Liability $282.00K; Operating Lease, Liability as first filed $338.00K.
- 2023-12-31: Operating Lease, Liability $342.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $286.00K 10-K · filed 2026-03-27 | |
| 2025-06-30 | $256.00K 10-Q · filed 2025-08-12 | |
| 2024-12-31 | $282.00K 10-Q · filed 2025-08-12 | $338.00K 10-K · filed 2025-03-26 |
| 2023-12-31 | $342.00K 10-K · filed 2024-03-26 | |
| 2022-12-31 | $395.00K 10-K/A · filed 2023-03-28 | |
| 2021-12-31 | $449.00K 10-K · filed 2022-03-25 | |
| 2020-03-31 | $404.00K 10-Q · filed 2020-05-08 | |
| 2019-03-31 | $442.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |